Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568045244> ?p ?o ?g. }
- W2568045244 endingPage "294" @default.
- W2568045244 startingPage "288" @default.
- W2568045244 abstract "Abstract Background: Radiotherapy with procarbazine, lomustine, and vincristine improves overall survival (OS) in patients with 1p19q co-deleted anaplastic oligodendroglioma/anaplastic oligoastrocytoma. Methods: This retrospective analysis investigated outcomes in patients with 1p19q co-deleted/partially deleted oligodendroglioma, oligoastrocytoma, anaplastic oligodendroglioma, or anaplastic oligoastrocytoma. OS and progression-free survival (PFS) were analyzed using the Kaplan-Meier method and prognostic factors using the Cox proportional hazard model. Results: A total of 106 patients (between December 1997 and December 2013) were included. Median age was 40 years (19-66), 58 were male (55%), Eastern Cooperative Oncology Group performance status was 0 in 80 patients (75%). 1p19q status was co-deleted in 66 (62%), incompletely co-deleted in 27 (25%), and 1p or 19q loss alone in four (4%) and nine (8%) patients, respectively. Isocitrate dehydrogenase-1 R132H mutation was found in 67 of 85 patients with sufficient material. Upfront treatment was given in 72 (68%) patients and temozolomide alone in 52 (49%). Median time to radiotherapy in 47 patients (44%) was 34.7 months and 41.2 months in 9 patients with co-deleted/incompletely co-deleted anaplastic oligodendroglioma/anaplastic oligoastrocytoma who received upfront temozolomide alone. Median OS was not reached and 5-year OS was 91% for all groups (median follow-up, 5.1 years). On multivariable analysis for all patients, receipt of therapy upfront versus none (p=0.04), PS 1 versus 0 (p<0.001) and 1p19q co-deletion/incomplete deletion versus 1p or 19q loss alone (p=0.005) were prognostic for PFS. Isocitrate dehydrogenase-1 status was not prognostic for PFS. Conclusions: With similar survival patterns in low-grade/anaplastic gliomas, molecular characteristics may be more important than histological grade. Longer follow-up and results of prospective trials are needed for definitive guidance on treatment of these patients." @default.
- W2568045244 created "2017-01-13" @default.
- W2568045244 creator A5002890512 @default.
- W2568045244 creator A5006549117 @default.
- W2568045244 creator A5017894781 @default.
- W2568045244 creator A5025331599 @default.
- W2568045244 creator A5041768679 @default.
- W2568045244 creator A5044352979 @default.
- W2568045244 creator A5051051033 @default.
- W2568045244 creator A5068398472 @default.
- W2568045244 creator A5069616282 @default.
- W2568045244 creator A5080459908 @default.
- W2568045244 creator A5090451343 @default.
- W2568045244 date "2017-01-09" @default.
- W2568045244 modified "2023-10-02" @default.
- W2568045244 title "Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas" @default.
- W2568045244 cites W1536266814 @default.
- W2568045244 cites W1812256879 @default.
- W2568045244 cites W1968466970 @default.
- W2568045244 cites W1997502785 @default.
- W2568045244 cites W2001493754 @default.
- W2568045244 cites W2015660037 @default.
- W2568045244 cites W2019406352 @default.
- W2568045244 cites W2029764040 @default.
- W2568045244 cites W2048796627 @default.
- W2568045244 cites W2066343654 @default.
- W2568045244 cites W2069059931 @default.
- W2568045244 cites W2103672421 @default.
- W2568045244 cites W2105526612 @default.
- W2568045244 cites W2133865472 @default.
- W2568045244 cites W2145247163 @default.
- W2568045244 cites W2147013683 @default.
- W2568045244 cites W2158565915 @default.
- W2568045244 cites W2159623602 @default.
- W2568045244 cites W2160382843 @default.
- W2568045244 cites W2461273419 @default.
- W2568045244 cites W2921076789 @default.
- W2568045244 doi "https://doi.org/10.1017/cjn.2016.420" @default.
- W2568045244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28488951" @default.
- W2568045244 hasPublicationYear "2017" @default.
- W2568045244 type Work @default.
- W2568045244 sameAs 2568045244 @default.
- W2568045244 citedByCount "11" @default.
- W2568045244 countsByYear W25680452442017 @default.
- W2568045244 countsByYear W25680452442019 @default.
- W2568045244 countsByYear W25680452442020 @default.
- W2568045244 countsByYear W25680452442021 @default.
- W2568045244 countsByYear W25680452442022 @default.
- W2568045244 crossrefType "journal-article" @default.
- W2568045244 hasAuthorship W2568045244A5002890512 @default.
- W2568045244 hasAuthorship W2568045244A5006549117 @default.
- W2568045244 hasAuthorship W2568045244A5017894781 @default.
- W2568045244 hasAuthorship W2568045244A5025331599 @default.
- W2568045244 hasAuthorship W2568045244A5041768679 @default.
- W2568045244 hasAuthorship W2568045244A5044352979 @default.
- W2568045244 hasAuthorship W2568045244A5051051033 @default.
- W2568045244 hasAuthorship W2568045244A5068398472 @default.
- W2568045244 hasAuthorship W2568045244A5069616282 @default.
- W2568045244 hasAuthorship W2568045244A5080459908 @default.
- W2568045244 hasAuthorship W2568045244A5090451343 @default.
- W2568045244 hasBestOaLocation W25680452441 @default.
- W2568045244 hasConcept C126322002 @default.
- W2568045244 hasConcept C143998085 @default.
- W2568045244 hasConcept C167135981 @default.
- W2568045244 hasConcept C181199279 @default.
- W2568045244 hasConcept C207103383 @default.
- W2568045244 hasConcept C2776694085 @default.
- W2568045244 hasConcept C2776755627 @default.
- W2568045244 hasConcept C2777150147 @default.
- W2568045244 hasConcept C2777389519 @default.
- W2568045244 hasConcept C2777931997 @default.
- W2568045244 hasConcept C2778227246 @default.
- W2568045244 hasConcept C2778880634 @default.
- W2568045244 hasConcept C2779083369 @default.
- W2568045244 hasConcept C2779112685 @default.
- W2568045244 hasConcept C2779429289 @default.
- W2568045244 hasConcept C2779434656 @default.
- W2568045244 hasConcept C2780739268 @default.
- W2568045244 hasConcept C2910969760 @default.
- W2568045244 hasConcept C44249647 @default.
- W2568045244 hasConcept C502942594 @default.
- W2568045244 hasConcept C50382708 @default.
- W2568045244 hasConcept C509974204 @default.
- W2568045244 hasConcept C55493867 @default.
- W2568045244 hasConcept C71924100 @default.
- W2568045244 hasConcept C86803240 @default.
- W2568045244 hasConceptScore W2568045244C126322002 @default.
- W2568045244 hasConceptScore W2568045244C143998085 @default.
- W2568045244 hasConceptScore W2568045244C167135981 @default.
- W2568045244 hasConceptScore W2568045244C181199279 @default.
- W2568045244 hasConceptScore W2568045244C207103383 @default.
- W2568045244 hasConceptScore W2568045244C2776694085 @default.
- W2568045244 hasConceptScore W2568045244C2776755627 @default.
- W2568045244 hasConceptScore W2568045244C2777150147 @default.
- W2568045244 hasConceptScore W2568045244C2777389519 @default.
- W2568045244 hasConceptScore W2568045244C2777931997 @default.
- W2568045244 hasConceptScore W2568045244C2778227246 @default.
- W2568045244 hasConceptScore W2568045244C2778880634 @default.